← Evidence map

ArticleHuman vaccines & immunotherapeutics2024

A novel orf virus vector-based COVID-19 booster vaccine shows cross-neutralizing activity in the absence of anti-vector neutralizing immunity.

Ute Klinkardt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

8 papers cite it

2024
2025
2026
this papercites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 39397784